Hugo Ta

Gilead Sciences
Associate Director, Quality Policy and Advocacy
Hugo Ta is an Associate Director in Quality Policy & Advocacy at Gilead Sciences. In this position, Hugo works within Gilead’s global policy, advisory, and intelligence community to navigate the regulatory landscape—especially as it relates to Quality, CGMP, and AI. Hugo also collaborates with internal and external stakeholders on several industry organizations to support harmonization and innovation. Hugo holds a bachelor’s in mathematics from the University of California, Berkeley.

Related Articles

standard-quality-control-collage-concept
iSpeak Blog
Elevating Pharmaceutical Quality: Insights from the FDA’s Office of Quality Surveillance and ISPE’s APQ Program

Every dose of medicine represents a promise of quality—a commitment to safety, efficacy, and availability for the patients who depend on it. At the 2024 ISPE Annual Meeting & Expo, Jennifer Maguire, PhD, Director of the US Food and Drug Administration’s (US FDA) Office of Quality Surveillance (OQS), outlined how the agency is transforming its approach to pharmaceutical quality surveillance...